Hospital
Okanogan Douglas County Hospital Dist 1
Okanogan Douglas County Hospital Dist 1 was paid $5.28M by Medicaid between Jan 2018 and Nov 2024, across 79 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.
33Billing provider infoOKANOGAN DOUGLAS COUNTY HOSPITAL DIST 1
BREWSTER, WA 98812
BREWSTER, WA 98812
33aNPI1356305395assigned 04/14/2006
33bProvider typeCritical Access Hospital
28Total paid$5.28M
24GClaims56,300
24DCodes billed79
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Washington
Rank by total paid#21 of 30
Median peer was paid$9.10M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,522 | $889K | |
| 2019 | 9,693 | $784K | |
| 2020 | 7,260 | $582K | |
| 2021 | 8,146 | $737K | |
| 2022 | 7,822 | $898K | |
| 2023 | 7,064 | $765K | |
| 2024incomplete | 4,793 | $630K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 5,983 | 5,459 | $1.24M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 3,013 | 2,328 | $849K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15% | 2,438 | 1,711 | $804K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.6% | 3,223 | 2,987 | $453K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.9% | 1,639 | 1,374 | $208K |
| 80053 | Comprehensive metabolic panel | 3.2% | 5,156 | 4,220 | $170K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.9% | 1,606 | 1,280 | $152K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 4,491 | 3,660 | $121K |
| G0378 | Hospital observation service, per hour | 2.1% | 255 | 111 | $112K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.9% | 569 | 531 | $99K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 1,671 | 1,481 | $97K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.8% | 306 | 194 | $95K |
67 more codes
| 36415 | Collection of venous blood by venipuncture | 1.7% | 7,198 | $88K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.5% | 1,143 | $82K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 1,553 | $77K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.2% | 131 | $64K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.0% | 377 | $54K |
| 84484 | <1% | 1,034 | $45K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,587 | $41K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 669 | $37K |
| 83690 | <1% | 1,247 | $32K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 126 | $32K |
| 87428 | <1% | 386 | $27K | |
| 85027 | <1% | 1,019 | $27K | |
| 81003 | <1% | 1,502 | $22K | |
| 81001 | <1% | 1,092 | $18K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 340 | $17K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 36 | $16K |
| 82150 | <1% | 511 | $13K | |
| 81025 | <1% | 552 | $13K | |
| 87081 | <1% | 389 | $12K | |
| 83605 | <1% | 257 | $12K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 238 | $12K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 146 | $12K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 952 | $11K |
| 80306 | <1% | 29 | $10K | |
| 76801 | <1% | 58 | $10K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 273 | $10K |
| 85610 | <1% | 576 | $8K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 445 | $8K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 66 | $8K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 188 | $7K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 150 | $6K |
| 59025 | Fetal non-stress test | <1% | 32 | $6K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 24 | $5K |
| 85730 | <1% | 250 | $4K | |
| 96376 | <1% | 41 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 72 | $3K |
| 85007 | <1% | 108 | $3K | |
| 87040 | <1% | 106 | $3K | |
| 87430 | <1% | 84 | $3K | |
| 87486 | <1% | 49 | $2K | |
| 87581 | <1% | 49 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 13 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 26 | $2K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 19 | $2K |
| 86140 | <1% | 26 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 41 | $1K |
| 83735 | <1% | 48 | $1K | |
| 0011A | <1% | 66 | $1K | |
| 73610 | <1% | 13 | $1K | |
| 87186 | <1% | 29 | $1K | |
| 84702 | <1% | 12 | $1K | |
| 73110 | <1% | 13 | $982.81 | |
| 87400 | <1% | 13 | $923.54 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 64 | $897.09 |
| 85379 | <1% | 16 | $777.20 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 31 | $709.18 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 13 | $464.92 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 20 | $414.18 |
| 0012A | <1% | 19 | $324.80 | |
| 87088 | <1% | 16 | $301.60 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 80 | $290.27 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15 | $32.62 |
| 91301 | 0% | 88 | $0.00 | |
| 80320 | 0% | 28 | $0.00 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 0% | 110 | $0.00 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 33 | $0.00 |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMUNSON, JENNIFER (CFO)
| Provider | Location | Paid |
|---|---|---|
| Okanogan Douglas County Hospital Dist1 | Brewster, WA | $31K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.